METATYROSINE IN THE TREATMENT OF PARKINSONISM

作者: M. Sandler , S.J. Corne , R. Stephens , K.M. Shaw , K.R. Hunter

DOI: 10.1016/S0140-6736(72)92006-5

关键词:

摘要:

参考文章(9)
Julián de Ajuriaguerra, Monoamines et système nerveux central Georg. ,(1962)
W. Birkmayer, O. Hornykiewicz, Weitere experimentelle Untersuchungen über L-DOPA beim Parkinson-Syndrom und Reserpin-Parkinsonismus European Archives of Psychiatry and Clinical Neuroscience. ,vol. 206, pp. 367- 381 ,(1964) , 10.1007/BF00341704
D. B. CALNE, M. SANDLER, L-Dopa and Parkinsonism Nature. ,vol. 226, pp. 21- 24 ,(1970) , 10.1038/226021A0
Nils-Erik Andén, Sherrel G. Butcher, Kjell Fuxe, Protection of the neostriatal dopamine stores against reserpine by local treatment with metatyramine. Pharmacology & Toxicology. ,vol. 28, pp. 39- 48 ,(2009) , 10.1111/J.1600-0773.1969.TB00527.X
M. SANDLER, B. L. GOODWIN, C. R. J. RUTHVEN, D. B. CALNE, Therapeutic implications in Parkinsonism of m-tyramine formation from L-dopa in man. Nature. ,vol. 229, pp. 414- 416 ,(1971) , 10.1038/229414A0
Arvid Carlsson, Margit Lindqvist, Metatyrosine as a tool for selective protection of catecholamine stores against reserpine European Journal of Pharmacology. ,vol. 2, pp. 187- 192 ,(1967) , 10.1016/0014-2999(67)90085-4
Peter Schnohr, Longevity and causes of death in male athletic champions. The Lancet. ,vol. 298, pp. 1364- 1366 ,(1971) , 10.1016/S0140-6736(71)92377-4